<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005204A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005204</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13923459</doc-number><date>20130621</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>496</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>9</main-group><subgroup>10</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>496</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>9</main-group><subgroup>10</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>51425407</main-classification></classification-national><invention-title id="d0e43">ITRACONAZOLE COMPOSITIONS WITH IMPROVED BIOAVAILABILITY</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>11997256</doc-number><date>20090216</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8486456</doc-number></document-id></parent-grant-document><parent-pct-document><document-id><country>WO</country><doc-number>PCT/EP2006/007839</doc-number><date>20060808</date></document-id></parent-pct-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13923459</doc-number></document-id></child-doc></relation></continuation></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>BARRIER THERAPEUTICS</orgname><address><city>Princeton</city><state>NJ</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>ABBOTT GMBH &#x26; CO. KG</orgname><address><city>Wiesbaden</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Berndl</last-name><first-name>Gunther</first-name><address><city>Herxheim am Berg</city><country>DE</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Degenhardt</last-name><first-name>Matthias</first-name><address><city>Limburgerhof</city><country>DE</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>M&#xe4;gerlein</last-name><first-name>Markus</first-name><address><city>Mannheim</city><country>DE</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Dispersyn</last-name><first-name>Gerrit</first-name><address><city>Princeton</city><state>NJ</state><country>US</country></address></addressbook></inventor></inventors></us-parties></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">A solid dispersion product comprising itraconazole and hydroxypropyl methylcellulose, which satisfies the Formula 0.35&#x3e;&#x394;H<sub>tr </sub>(1) (wherein &#x394;H<sub>t</sub>, represents the endotherm (J/g) accompanying a transition at about 240&#xb0; C.). The solid dispersion product shows an improved bioavailability.</p></abstract></us-patent-application>